
Brian I. Rini, MD, discusses current thinking regarding the use of targeted agents in the treatment of kidney cancer.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply current guidelines for the treatment of renal cell carcinoma
- Discuss the use of nephrectomy in the treatment of patients with renal cell carcinoma
- Compare recent clinical trial data regarding first-line treatment of renal cell carcinoma
- Describe recent studies of second-line therapies, including targeted agents and combination regimens, for the treatment of renal cell carcinoma
- List patient-specific factors that guide therapy decisions in the setting of renal cell carcinoma